|

Abiraterone acetate (Zytiga®) 250 mg or 500 mg tablets Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • ORIC Pharmaceuticals1

Indications

  • Metastatic Prostate Cancer1
  • Cancer1

Colorado Springs, Colorado1 trial

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Rocky Mountain Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.